Cart
sales@molnova.com
Fructosylvaline
CAS No. 10003-64-2
Fructosylvaline( —— )
Catalog No. M34078 CAS No. 10003-64-2
Fructosylvaline（Fru-val） is present in miso, white wine and sake and has been associated with oxidative browning of white wine and sake.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 188 | In Stock |
|
| 10MG | 278 | In Stock |
|
| 25MG | 506 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFructosylvaline
-
NoteResearch use only, not for human use.
-
Brief DescriptionFructosylvaline（Fru-val） is present in miso, white wine and sake and has been associated with oxidative browning of white wine and sake.
-
DescriptionFructosylvaline（Fru-val） is present in miso, white wine and sake and has been associated with oxidative browning of white wine and sake.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10003-64-2
-
Formula Weight279.29
-
Molecular FormulaC11H21NO7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](NCC([C@H]([C@@H]([C@@H](CO)O)O)O)=O)([C@H](C)C)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Morin Hydrate
Morin hydrate(Aurantica) is a flavonoid isolated from Maclura pomifera (Osage orange), Maclura tinctoria (old fustic) and from leaves of Psidium guajava (common guava).
-
NS-3-008 HCl
NS-3-008 HCl is a transcriptional G0/G1 switch 2 (G0s2) inhibitor( IC50 of 2.25 μM).Administration of NS-3-008 inhibited the expression of G0s2 in healthy mice liver.?
-
Leuprolide Acetate
Leuprolide is an agonist at pituitary GnRH receptors. Leuprorelin is a gonadotropin-releasing hormone (GnRH) analog used to treat a wide range of sex hormone-related disorders including advanced prostatic cancer endometriosis and precocious puberty.
